Early Detection of Prostate Cancer of Syrian Men
Launched by AL-HAWASH PRIVATE UNIVERSITY · Jul 18, 2025
Trial Information
Current as of July 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study aims to assess the awareness, attitudes, and practices regarding prostate cancer screening among men in the middle region of Syria, with the goal of identifying barriers to early detection and informing public health interventions.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Men aged 40 years and older residing in the middle region of Syria.
- Exclusion Criteria:
- • Men with a previous diagnosis of prostate cancer.
About Al Hawash Private University
Al-Hawash Private University is an academic institution dedicated to advancing education and research in various fields, including healthcare and medical sciences. Committed to fostering innovation and improving patient outcomes, the university actively engages in clinical research and collaborates with healthcare organizations to support the development of evidence-based medical practices. Through its clinical trial sponsorship, Al-Hawash Private University aims to contribute to scientific knowledge and promote advancements in health and medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Homs, , Syrian Arab Republic
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported